8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): July 13, 2005 (July 13, 2005)

HCA INC.

(Exact name of registrant as specified in its charter)

Delaware	001-11239	75-2497104
(State or other jurisdiction of incorporation)	(Commission File Number)	(I.R.S. Employer
		Identification No.)

One Park Plaza, Nashville, Tennessee	37203
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code: (615) 344-9551

Not Applicable

(Former name or former address, if changed since last report)

     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

     o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

TABLE OF CONTENTS

	Item 2.02. Results of Operations and Financial Condition
	Item 7.01. Regulation FD Disclosure
	Item 9.01. Financial Statements and Exhibits
SIGNATURES
EXHIBIT INDEX
Ex-99.1 Press Release

Item 2.02. Results of Operations and Financial Condition

     On July 13, 2005, HCA Inc. (the “Company”) issued a press release announcing, among other matters, its preliminary results of operations for the second quarter ended June 30, 2005, the text of which is set forth as Exhibit 99.1.

Item 7.01. Regulation FD Disclosure

     On July 13, 2005, the Company issued a press release announcing, among other matters, its preliminary results of operations for the second quarter ended June 30, 2005, the text of which is set forth as Exhibit 99.1.

Item 9.01. Financial Statements and Exhibits

(c)

Exhibit
Number	Exhibit Title
99.1	Press Release dated July 13, 2005

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

HCA INC.
By:	/s/ R. Milton Johnson
	R. Milton Johnson
	Executive Vice President and Chief Financial Officer

Date: July 13, 2005

EXHIBIT INDEX

Exhibit
Number	Exhibit Title
99.1	Press Release dated July 13, 2005

EX-99.1

                                                                    EXHIBIT 99.1


[HCA LOGO]                                                                  NEWS
- --------------------------------------------------------------------------------
                                                           FOR IMMEDIATE RELEASE
INVESTOR CONTACT:                                          MEDIA CONTACT:
Mark Kimbrough                                             Jeff Prescott
615-344-2688                                               615-344-5708

                    HCA Previews Second Quarter 2005 Earnings

Nashville, Tenn., July 13, 2005 --- HCA (NYSE: HCA) today announced that
preliminary results for its second quarter ended June 30, 2005 indicate that net
income is expected to be in the range of $0.88 to $0.92 per diluted share,
compared to $0.72 per diluted share for the prior year's second quarter. The
Company's operating results for the second quarter are expected to include the
following:

         o        favorable tax settlement related to the Company's divesture of
                  certain non-core business units in 1998 and 2001 of
                  approximately $48 million, or $0.11 per diluted share;

         o        recognition of a previously deferred gain on the Company's
                  sale of certain medical office buildings (the MedCap
                  properties) of approximately $29 million pretax, or $0.04 per
                  diluted share; and

         o        additional depreciation expense of approximately $30 million,
                  or $0.04 per diluted share, to correct accumulated
                  depreciation and assure a consistent application of the
                  Company's accounting policy relative to certain short-lived
                  medical equipment.

Also, the Company recognized a reduction in its estimated professional liability
insurance reserves of approximately $36 million pretax, or $0.05 per diluted
share, during the second quarter of 2005. Results for the second quarter of 2004
included a reduction in its estimated professional liability reserves of
approximately $59 million pretax, or $0.07 per diluted share.

For the second quarter of 2005, same facility admissions are expected to reflect
a decrease of approximately 0.3 percent, while same facility equivalent
admissions are expected to reflect an increase of approximately 1.2 percent
compared to the second quarter of 2004. Preliminary results indicate same
facility revenues are expected to increase approximately 4.3 percent to
approximately $6.0 billion and same facility net revenue per equivalent
admission is expected to increase approximately 3.1 percent in the second
quarter of 2005 compared to the second quarter of 2004. Adjusting for the effect
of approximately $183 million of discounts provided to the uninsured during the
second quarter of 2005, same facility revenues are expected to increase
approximately 7.5 percent and same facility net revenue per equivalent admission
is expected to increase approximately 6.2 percent in the second quarter of 2005
compared to the second quarter of 2004.

                                       1



The provision for doubtful accounts for the second quarter is expected to
approximate $541 million, or 8.9 percent of revenues, compared to $661 million,
or 11.3 percent of revenues in the second quarter of 2004. Adjusting for the
effect of the uninsured discounts, the expected provision for doubtful accounts
for the second quarter of 2005 would be $725 million, or 11.6 percent of
revenues. Uninsured patient admissions increased approximately 5 percent in the
second quarter compared to the prior year period. The Company's uninsured
discount policy, which became effective January 1, 2005, lowers revenues and the
provision for doubtful accounts by generally corresponding amounts.

The Company's common shares used to compute diluted earnings per share for the
second quarter of 2005 approximated 451.7 million, compared to 490.3 million
shares in the prior year's second quarter and 435.7 million shares for the first
quarter of 2005.

With today's announcement, the Company is reaffirming its earnings guidance for
2005 of $3.05 to $3.20 per diluted share, excluding gains on sales of assets,
impairments and tax settlements.

The Company plans to report its final second quarter and six months results for
the periods ended June 30, 2005 on July 27th and will hold a conference call and
web-cast to discuss the quarter and six months results at that time.


         CAUTIONARY NOTE REGARDING FORWARD LOOKING STATEMENTS

This press release contains forward-looking statements based on current
management expectations. Those forward-looking statements include all statements
regarding our estimated results of operations including those relating to the
Company's preliminary results for the second quarter of 2005, estimated results
for future periods and all statements other than those made solely with respect
to historical fact. Numerous risks, uncertainties and other factors may cause
actual results to differ materially from those expressed in any forward-looking
statements. These factors include, but are not limited to, (i) the finalization
of the Company's financial statements for the second quarter, (ii) increases in
the amount and risk of collectability of uninsured accounts and deductibles and
co-pay amounts for insured accounts, (iii) the ability to achieve operating and
financial targets, achieve expected levels of patient volumes and control the
costs of providing services, (iv) the highly competitive nature of the health
care business, (v) the efforts of insurers, health care providers and others to
contain health care costs, (vi) possible changes in the Medicare, Medicaid and
other state programs that may impact reimbursements to health care providers and
insurers, (vii) the ability to attract and retain qualified management and other
personnel, including affiliated physicians, nurses and medical support
personnel, (viii) potential liabilities and other claims that may be asserted
against the Company, (ix) fluctuations in the market value of the Company's
common stock, (x) the impact of the Company's charity care and uninsured
discounting policy changes, (xi) changes in accounting practices, (xii) changes
in general economic conditions, (xiii) future divestitures which may result in
charges, (xiv) changes in revenue mix and the ability to enter into and renew
managed care provider arrangements on acceptable terms, (xv) the availability
and terms of capital to fund the expansion of the Company's business, (xvi)
changes in business strategy or development plans,

                                       2




(xvii) delays in receiving payments for services provided, (xviii) the possible
enactment of Federal or state health care reform, (xix) the outcome of pending
and any future tax audits, appeals and litigation associated with the Company's
tax positions, (xx) the outcome of the Company's continuing efforts to monitor,
maintain and comply with appropriate laws, regulations, policies and procedures
and the Company's corporate integrity agreement with the government, (xxi)
changes in Federal, state or local regulations affecting the health care
industry, (xxii) the ability to develop and implement the payroll and human
resources information systems within the expected time and cost projections and,
upon implementation, to realize the expected benefits and efficiencies, (xxiii)
maintaining the increased quarterly cash dividend rate for the entire fiscal
year, and (xxiv) other risk factors detailed in the Company's filings with the
SEC. Many of the factors that will determine the Company's future results are
beyond the ability of the Company to control or predict. In light of the
significant uncertainties inherent in the forward-looking statements contained
herein, readers should not place undue reliance on forward-looking statements,
which reflect management's views only as of the date hereof. The Company
undertakes no obligation to revise or update any forward-looking statements, or
to make any other forward-looking statements, whether as a result of new
information, future events or otherwise.

All references to "Company" and "HCA" as used throughout this document refer to
HCA Inc. and its affiliates.


                                       3